ENDLOS-TURBO PUT - VERTEX PHARMACEUTICALS | Real-time Boerse Frankfurt Warrants 05:04:18 2024-06-26 EDT | ||
| 13.84 EUR | -0.65% |
|
| Current month | -9.55% | ||
| 1 month | -8.29% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about VERTEX PHARMACEUTICALS INCORPORATED
More news
| Date | Price | Change |
|---|---|---|
| 24-06-26 | 13.84 | -0.65% |
| 24-06-25 | 13.93 | +2.13% |
| 24-06-24 | 13.64 | -4.08% |
| 24-06-21 | 14.22 | +1.43% |
| 24-06-20 | 14.02 | -2.71% |
Real-time Boerse Frankfurt Warrants
Last update June 26, 2024 at 05:04 am
More quotesStatic data
| Product type | Certificat Turbo |
|---|---|
| Buy / Sell | PUT |
| Underlying | VERTEX PHARMACEUTICALS INCORPORATED |
| Issuer | DZ BANK |
| WKN | DJ8TBW |
| ISIN | DE000DJ8TBW0 |
| Date issued | 2024-01-24 |
| Strike | 620.8 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 16.17 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 21.55 € |
|---|---|
| Lowest since issue | 12.33 € |
| Spread | 0.13 € |
| Spread % | 0.93% |
Company Profile
Vertex Pharmaceuticals Incorporated specializes in the research, development and marketing of micromolecular drugs primarily for the treatment of cancers, viral, inflammatory and auto-immune diseases.
Net sales are distributed geographically as follows: the United States (61.2%), Europe (31.5%) and other (7.3%).
Sector
-
Ratings for Vertex Pharmaceuticals Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Vertex Pharmaceuticals Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
473.8
USD
Average target price
465.5
USD
Spread / Average Target
-1.75%
- Stock Market
- Certificates
- Certificat
